| Tyler Carlage is a Fellow in Technical Development at Moderna. He has over 20 years of industry experience in Analytical Development. At Moderna, Tyler leads the Technical Development team for the mRNA-1273 Covid vaccine program and leads a mass spectrometry characterization group in Analytical Development. Tyler has led numerous comparability assessments for the mRNA-1273 vaccine including the introduction of new mRNA-1273 variant vaccines targeting the Omicron subvariants of SARS-CoV-2. Prior to Moderna, Tyler has worked at Biogen and Alnylam Pharmaceuticals, where he has focused on method development and characterization of biologics and siRNA, and leading analytical activities for early and late-stage programs. Tyler obtained his B.S. in Biochemistry from Tufts University and his M.S and Ph.D in Chemistry from Northeastern University. |
